{"gene":"TBCB","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2006,"finding":"TBCB overexpression depolymerizes microtubules in vivo. TBCB forms a binary complex with TBCE that greatly enhances TBCE's efficiency in dissociating tubulin heterodimers both in vivo and in vitro. After heterodimer dissociation, TBCE, TBCB, and α-tubulin form a ternary complex, while free β-tubulin is recovered by TBCA.","method":"Overexpression assays, in vitro tubulin dissociation assays, co-immunoprecipitation/complex formation assays","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro reconstitution of tubulin dissociation combined with in vivo overexpression and complex characterization, multiple orthogonal methods in one study","pmids":["17184771"],"is_preprint":false},{"year":2008,"finding":"TBCB stably interacts with CCT-generated α-tubulin folding intermediates as an obligate step in de novo tubulin heterodimer formation. A pachygyria-causing TUBA1A mutation (R264C) disrupts this stable interaction with TBCB, thereby reducing the efficiency of tubulin heterodimer assembly.","method":"In vitro tubulin folding/assembly assays, co-immunoprecipitation of TBCB with CCT-generated intermediates, functional comparison of wild-type vs. R264C mutant α-tubulin","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro folding reconstitution combined with mutant analysis and co-IP, multiple orthogonal methods establishing the TBCB–α-tubulin interaction step","pmids":["18199681"],"is_preprint":false},{"year":2015,"finding":"Cryo-EM and X-ray crystallography revealed the 3D structure of the human TBCE–TBCB–α-tubulin (αEB) ternary complex formed upon heterodimer dissociation. Heterodimer dissociation is an energy-independent process driven by a steric interaction between β-tubulin and the TBCE CAP-Gly and LRR domains. The protruding arrangement of UBL domains in the αEB complex suggests direct interaction with the proteasome, mediating α-tubulin degradation.","method":"Electron microscopy and image processing (3D reconstruction), X-ray crystallography of TBCE UBL domain, biochemical dissociation assays, atomic domain docking","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus cryo-EM structure combined with biochemical dissociation assays and domain docking, multiple rigorous orthogonal methods","pmids":["25908846"],"is_preprint":false},{"year":2017,"finding":"HILI (PIWIL2) interacts with TBCB, promotes binding of HSP90 to TBCB, and suppresses both Gigaxonin-mediated ubiquitination/degradation of TBCB and PAK1-induced phosphorylation of TBCB, thereby stabilizing TBCB protein levels and destabilizing microtubules.","method":"Co-immunoprecipitation of HILI–TBCB, HILI–HSP90–TBCB, and Gigaxonin–TBCB interactions; ubiquitination assays; phosphorylation assays; microtubule polymerization assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — reciprocal Co-IP and functional ubiquitination/phosphorylation assays in a single lab, multiple orthogonal methods but no independent replication","pmids":["28393858"],"is_preprint":false},{"year":2018,"finding":"Excess TBCB causes depolymerization and degradation of α-tubulin TUBA4A, establishing TBCB as a regulator of TUBA4A protein stability. Reduced miR-1825 leads to translational upregulation of TBCB, which in turn reduces TUBA4A levels and causes motor axon defects in vivo.","method":"Transcriptomic/proteomic analysis, miRNA manipulation, in vivo motor axon phenotype assay, western blot validation in patient tissue","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — combined transcriptomic/proteomic and in vivo model with patient tissue validation, single lab but multiple orthogonal approaches","pmids":["30030593"],"is_preprint":false},{"year":2020,"finding":"The Salmonella effector SseK1 binds TBCB (identified by yeast two-hybrid) and catalyzes N-acetylglucosamine addition to arginine residues on TBCB; this modification stabilizes the host microtubule cytoskeleton. The SseK1 DxD motif is required for both TBCB binding/modification and the cytoskeletal effect.","method":"Yeast two-hybrid screen, glycosyltransferase activity assay (in cellulo), DxD active-site mutagenesis, microtubule stability assay in HEK293T cells","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus active-site mutagenesis and functional cytoskeletal assay, single lab, multiple orthogonal methods","pmids":["32366039"],"is_preprint":false},{"year":2021,"finding":"TBCE/TBCB together dissociate tubulin heterodimers, and colchicine inhibits this dissociation, likely by interfering with TBCE–tubulin dimer interactions, leading to accumulation of free TBCA. The TBCE/TBCB + TBCA system recycles pre-existing tubulin heterodimers (rather than newly synthesized tubulins) to control the pool of free tubulin heterodimers and microtubule dynamics. Manipulation of TBCA levels by RNAi or overexpression decreased tubulin heterodimer levels, confirming functional coupling.","method":"In vitro tubulin dissociation assays with colchicine, RNAi knockdown and overexpression of TBCA, western blot of TBCA/β-tubulin complexes in colchicine-treated human cells, comparison with nocodazole/cold shock/cycloheximide controls","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro assays combined with RNAi and OE experiments and cell-based validation, single lab, multiple orthogonal methods","pmids":["33968934"],"is_preprint":false},{"year":1996,"finding":"TBCB (CKAP1) encodes a protein containing a CAP-Gly domain conserved among cytoskeleton-associated proteins; the CAP-Gly domain is thought to be essential for microtubule association. The gene maps to chromosome 19q13.11→q13.12.","method":"cDNA cloning from human fetal-brain library, Northern blot, FISH chromosomal mapping","journal":"Cytogenetics and cell genetics","confidence":"Low","confidence_rationale":"Tier 3–4 / Weak — initial cloning and mapping; CAP-Gly function in microtubule association is inferred from domain conservation, not directly demonstrated for this protein","pmids":["8978778"],"is_preprint":false},{"year":2025,"finding":"A homozygous loss-of-function variant in TBCB (p.Tyr197Asn) reduces TBCB protein levels in patient fibroblasts and causes a neurodevelopmental disorder with spastic paraparesis. The yeast ortholog ALF1 carrying the equivalent mutation shows increased benomyl sensitivity (a microtubule-destabilizing agent), consistent with impaired tubulin-folding function. A CRISPR-Cas9 homologous mutant in Drosophila displays reduced survival and impaired climbing, confirming an essential role of TBCB in neuronal/axonal function.","method":"Exome sequencing, western blot and immunofluorescence in patient fibroblasts, yeast ALF1 mutant benomyl sensitivity assay, CRISPR-Cas9 Drosophila model with climbing/survival phenotype","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function established via patient fibroblasts, yeast ortholog functional assay, and Drosophila CRISPR model with defined phenotypic readouts; single study but multiple orthogonal model systems","pmids":["40856104"],"is_preprint":false}],"current_model":"TBCB is a tubulin-folding chaperone that binds α-tubulin intermediates emerging from CCT and acts together with TBCE to dissociate αβ-tubulin heterodimers in an energy-independent, steric mechanism (structurally defined by cryo-EM/X-ray); the resulting TBCE–TBCB–α-tubulin ternary complex can direct α-tubulin toward proteasomal degradation, while free β-tubulin is captured by TBCA for recycling. TBCB protein stability is regulated by Gigaxonin-mediated ubiquitination, PAK1-mediated phosphorylation, and HSP90 interaction (modulated by HILI/PIWIL2), and its abundance is post-transcriptionally controlled by miR-1825; excess TBCB destabilizes microtubules and degrades specific α-tubulin isoforms (e.g., TUBA4A), while loss-of-function variants in TBCB cause neurodevelopmental disease with spastic paraparesis."},"narrative":{"mechanistic_narrative":"TBCB is a tubulin-folding cofactor that controls the cellular pool of αβ-tubulin heterodimers and thereby microtubule dynamics [PMID:17184771, PMID:33968934]. It stably engages α-tubulin folding intermediates emerging from the CCT chaperonin as an obligate step in de novo heterodimer formation; a pachygyria-causing TUBA1A R264C mutation disrupts this interaction and reduces assembly efficiency [PMID:18199681]. Acting together with TBCE, TBCB forms a binary complex that greatly enhances dissociation of αβ-tubulin heterodimers, after which TBCE, TBCB, and α-tubulin form a ternary complex while free β-tubulin is recovered by TBCA [PMID:17184771]. Structural work on the human TBCE–TBCB–α-tubulin complex established that dissociation is energy-independent, driven by steric interaction between β-tubulin and the TBCE CAP-Gly and LRR domains, with protruding UBL domains positioned to direct α-tubulin to the proteasome [PMID:25908846]; this TBCE/TBCB–TBCA system recycles pre-existing rather than newly synthesized heterodimers and is inhibited by colchicine [PMID:33968934]. TBCB abundance is tightly regulated: HILI (PIWIL2) promotes HSP90 binding and suppresses Gigaxonin-mediated ubiquitination and PAK1-mediated phosphorylation to stabilize TBCB and destabilize microtubules [PMID:28393858], while miR-1825 controls TBCB translation, and excess TBCB depolymerizes and degrades the α-tubulin isoform TUBA4A, causing motor axon defects [PMID:30030593]. The Salmonella effector SseK1 binds and Arg-GlcNAcylates TBCB to stabilize the host microtubule cytoskeleton [PMID:32366039]. A homozygous loss-of-function TBCB variant (p.Tyr197Asn) reduces TBCB protein levels and causes a neurodevelopmental disorder with spastic paraparesis, with corroborating microtubule-destabilization and neuronal phenotypes in yeast and Drosophila models [PMID:40856104].","teleology":[{"year":2006,"claim":"Established that TBCB does not act alone but partners with TBCE to actively dissociate tubulin heterodimers, defining its place in the tubulin-cofactor cycle.","evidence":"Overexpression, in vitro tubulin dissociation assays, and complex characterization showing TBCB enhances TBCE dissociation activity and forms a TBCE–TBCB–α-tubulin ternary complex with β-tubulin recovered by TBCA","pmids":["17184771"],"confidence":"High","gaps":["Did not resolve the atomic mechanism of dissociation","Fate of the ternary complex (e.g., degradation routing) not established"]},{"year":2008,"claim":"Showed TBCB acts upstream in biogenesis by capturing CCT-generated α-tubulin intermediates, making it an obligate step in de novo heterodimer formation rather than only a recycling factor.","evidence":"In vitro folding/assembly reconstitution, co-IP of TBCB with CCT intermediates, and functional comparison of wild-type vs. R264C TUBA1A","pmids":["18199681"],"confidence":"High","gaps":["Did not define how TBCB hands off intermediates downstream","Generalizability across α-tubulin isoforms not tested"]},{"year":2015,"claim":"Defined the structural and energetic basis of heterodimer dissociation, revealing it is steric/energy-independent and positions α-tubulin for proteasomal degradation.","evidence":"Cryo-EM 3D reconstruction of the TBCE–TBCB–α-tubulin complex, X-ray crystallography of the TBCE UBL domain, and biochemical dissociation assays with domain docking","pmids":["25908846"],"confidence":"High","gaps":["Direct proteasome engagement via UBL domains inferred from geometry, not demonstrated","TBCB-specific contributions versus TBCE within the complex not fully separated"]},{"year":2017,"claim":"Identified post-translational control of TBCB stability, linking HILI/HSP90, Gigaxonin ubiquitination, and PAK1 phosphorylation to microtubule destabilization.","evidence":"Reciprocal co-IP of HILI–TBCB, HILI–HSP90–TBCB, and Gigaxonin–TBCB, plus ubiquitination, phosphorylation, and microtubule polymerization assays in a single lab","pmids":["28393858"],"confidence":"Medium","gaps":["No independent replication","Phosphorylation sites and ubiquitination acceptor residues on TBCB not mapped"]},{"year":2018,"claim":"Connected TBCB dosage to isoform-specific tubulin degradation and an in vivo neuronal phenotype, showing miR-1825 sets TBCB levels that govern TUBA4A stability.","evidence":"Transcriptomic/proteomic analysis, miRNA manipulation, in vivo motor axon phenotype assay, and western blot validation in patient tissue","pmids":["30030593"],"confidence":"Medium","gaps":["Mechanism of TUBA4A selectivity over other α-tubulins unresolved","Single lab, no independent replication"]},{"year":2020,"claim":"Revealed TBCB as a target of bacterial subversion, with the Salmonella effector SseK1 modifying TBCB to stabilize host microtubules.","evidence":"Yeast two-hybrid screen, in cellulo glycosyltransferase assay, DxD active-site mutagenesis, and microtubule stability assay in HEK293T cells","pmids":["32366039"],"confidence":"Medium","gaps":["Arg-GlcNAcylated residues on TBCB not mapped","How modification mechanistically alters TBCB function in the cofactor cycle unknown"]},{"year":2021,"claim":"Clarified that the TBCE/TBCB + TBCA system recycles pre-existing heterodimers to control free tubulin pools, and that colchicine blocks this dissociation step.","evidence":"In vitro dissociation assays with colchicine, TBCA RNAi and overexpression, and western blot of TBCA/β-tubulin complexes in human cells with control comparisons","pmids":["33968934"],"confidence":"Medium","gaps":["Direct colchicine binding site within the dissociation machinery not defined","Single lab"]},{"year":2025,"claim":"Established TBCB loss-of-function as a cause of human neurodevelopmental disease, tying its tubulin-folding role to axonal/neuronal function across species.","evidence":"Exome sequencing, patient fibroblast western blot/immunofluorescence, yeast ALF1 mutant benomyl-sensitivity assay, and CRISPR-Cas9 Drosophila climbing/survival phenotype","pmids":["40856104"],"confidence":"Medium","gaps":["Single index variant/family; allelic spectrum unknown","Cellular mechanism linking reduced TBCB to spastic paraparesis not defined"]},{"year":null,"claim":"How TBCB dosage, post-translational regulation, and isoform-selective α-tubulin handling integrate to produce tissue-specific neuronal vulnerability remains open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural account of how TBCB discriminates α-tubulin isoforms such as TUBA4A","Regulatory inputs (Gigaxonin, PAK1, HILI, miR-1825) not integrated into a quantitative model of TBCB abundance in neurons"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,1,2,6]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,6]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,7]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,6]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,1,2]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,3]}],"complexes":["TBCE–TBCB–α-tubulin ternary complex"],"partners":["TBCE","TBCA","CCT","PIWIL2","HSP90","GAN","PAK1","SSEK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q99426","full_name":"Tubulin-folding cofactor B","aliases":["Cytoskeleton-associated protein 1","Cytoskeleton-associated protein CKAPI","Tubulin-specific chaperone B"],"length_aa":244,"mass_kda":27.3,"function":"Binds to alpha-tubulin folding intermediates after their interaction with cytosolic chaperonin in the pathway leading from newly synthesized tubulin to properly folded heterodimer (PubMed:9265649). Involved in regulation of tubulin heterodimer dissociation. May function as a negative regulator of axonal growth (By similarity)","subcellular_location":"Cytoplasm; Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/Q99426/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/TBCB","classification":"Common Essential","n_dependent_lines":1172,"n_total_lines":1208,"dependency_fraction":0.9701986754966887},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SAR1B","stoichiometry":0.2},{"gene":"TUBA1B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TBCB","total_profiled":1310},"omim":[{"mim_id":"621382","title":"NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CHILDHOOD-ONSET SPASTIC PARAPLEGIA; NEDBSPG","url":"https://www.omim.org/entry/621382"},{"mim_id":"602529","title":"TUBULIN, ALPHA-1A; TUBA1A","url":"https://www.omim.org/entry/602529"},{"mim_id":"601303","title":"TUBULIN FOLDING COFACTOR B; TBCB","url":"https://www.omim.org/entry/601303"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":386.0}],"url":"https://www.proteinatlas.org/search/TBCB"},"hgnc":{"alias_symbol":["CG22","CKAPI"],"prev_symbol":["CKAP1"]},"alphafold":{"accession":"Q99426","domains":[{"cath_id":"3.10.20.90","chopping":"9-88","consensus_level":"high","plddt":96.1691,"start":9,"end":88},{"cath_id":"2.30.30.190","chopping":"156-230","consensus_level":"high","plddt":96.6544,"start":156,"end":230}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99426","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99426-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99426-F1-predicted_aligned_error_v6.png","plddt_mean":92.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TBCB","jax_strain_url":"https://www.jax.org/strain/search?query=TBCB"},"sequence":{"accession":"Q99426","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99426.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99426/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99426"}},"corpus_meta":[{"pmid":"17184771","id":"PMC_17184771","title":"Role of cofactors B (TBCB) and E (TBCE) in tubulin heterodimer dissociation.","date":"2006","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/17184771","citation_count":63,"is_preprint":false},{"pmid":"18199681","id":"PMC_18199681","title":"A pachygyria-causing alpha-tubulin mutation results in inefficient cycling with CCT and a deficient interaction with TBCB.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18199681","citation_count":41,"is_preprint":false},{"pmid":"30030593","id":"PMC_30030593","title":"Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS.","date":"2018","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/30030593","citation_count":38,"is_preprint":false},{"pmid":"25908846","id":"PMC_25908846","title":"The structure of the complex between α-tubulin, TBCE and TBCB reveals a tubulin dimer dissociation mechanism.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25908846","citation_count":38,"is_preprint":false},{"pmid":"33968934","id":"PMC_33968934","title":"Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33968934","citation_count":20,"is_preprint":false},{"pmid":"28393858","id":"PMC_28393858","title":"HILI destabilizes microtubules by suppressing phosphorylation and Gigaxonin-mediated degradation of TBCB.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28393858","citation_count":15,"is_preprint":false},{"pmid":"8978778","id":"PMC_8978778","title":"Cloning, expression, and mapping of CKAPI, which encodes a putative cytoskeleton-associated protein containing a CAP-GLY domain.","date":"1996","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8978778","citation_count":12,"is_preprint":false},{"pmid":"32366039","id":"PMC_32366039","title":"Tubulin Folding Cofactor TBCB is a Target of the Salmonella Effector Protein SseK1.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32366039","citation_count":7,"is_preprint":false},{"pmid":"37476188","id":"PMC_37476188","title":"High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia.","date":"2023","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37476188","citation_count":3,"is_preprint":false},{"pmid":"41570284","id":"PMC_41570284","title":"Multi-omics analysis identifies TBCB as a therapeutic target in sepsis-induced liver injury.","date":"2026","source":"International journal of surgery (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/41570284","citation_count":0,"is_preprint":false},{"pmid":"40856104","id":"PMC_40856104","title":"A founder variant in TBCB is associated with global developmental delay, autism spectrum, and spastic paraparesis.","date":"2025","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40856104","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7440,"output_tokens":2763,"usd":0.031883,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10007,"output_tokens":3255,"usd":0.065705,"stage2_stop_reason":"end_turn"},"total_usd":0.097588,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"TBCB overexpression depolymerizes microtubules in vivo. TBCB forms a binary complex with TBCE that greatly enhances TBCE's efficiency in dissociating tubulin heterodimers both in vivo and in vitro. After heterodimer dissociation, TBCE, TBCB, and α-tubulin form a ternary complex, while free β-tubulin is recovered by TBCA.\",\n      \"method\": \"Overexpression assays, in vitro tubulin dissociation assays, co-immunoprecipitation/complex formation assays\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro reconstitution of tubulin dissociation combined with in vivo overexpression and complex characterization, multiple orthogonal methods in one study\",\n      \"pmids\": [\"17184771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TBCB stably interacts with CCT-generated α-tubulin folding intermediates as an obligate step in de novo tubulin heterodimer formation. A pachygyria-causing TUBA1A mutation (R264C) disrupts this stable interaction with TBCB, thereby reducing the efficiency of tubulin heterodimer assembly.\",\n      \"method\": \"In vitro tubulin folding/assembly assays, co-immunoprecipitation of TBCB with CCT-generated intermediates, functional comparison of wild-type vs. R264C mutant α-tubulin\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro folding reconstitution combined with mutant analysis and co-IP, multiple orthogonal methods establishing the TBCB–α-tubulin interaction step\",\n      \"pmids\": [\"18199681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cryo-EM and X-ray crystallography revealed the 3D structure of the human TBCE–TBCB–α-tubulin (αEB) ternary complex formed upon heterodimer dissociation. Heterodimer dissociation is an energy-independent process driven by a steric interaction between β-tubulin and the TBCE CAP-Gly and LRR domains. The protruding arrangement of UBL domains in the αEB complex suggests direct interaction with the proteasome, mediating α-tubulin degradation.\",\n      \"method\": \"Electron microscopy and image processing (3D reconstruction), X-ray crystallography of TBCE UBL domain, biochemical dissociation assays, atomic domain docking\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus cryo-EM structure combined with biochemical dissociation assays and domain docking, multiple rigorous orthogonal methods\",\n      \"pmids\": [\"25908846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HILI (PIWIL2) interacts with TBCB, promotes binding of HSP90 to TBCB, and suppresses both Gigaxonin-mediated ubiquitination/degradation of TBCB and PAK1-induced phosphorylation of TBCB, thereby stabilizing TBCB protein levels and destabilizing microtubules.\",\n      \"method\": \"Co-immunoprecipitation of HILI–TBCB, HILI–HSP90–TBCB, and Gigaxonin–TBCB interactions; ubiquitination assays; phosphorylation assays; microtubule polymerization assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — reciprocal Co-IP and functional ubiquitination/phosphorylation assays in a single lab, multiple orthogonal methods but no independent replication\",\n      \"pmids\": [\"28393858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Excess TBCB causes depolymerization and degradation of α-tubulin TUBA4A, establishing TBCB as a regulator of TUBA4A protein stability. Reduced miR-1825 leads to translational upregulation of TBCB, which in turn reduces TUBA4A levels and causes motor axon defects in vivo.\",\n      \"method\": \"Transcriptomic/proteomic analysis, miRNA manipulation, in vivo motor axon phenotype assay, western blot validation in patient tissue\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — combined transcriptomic/proteomic and in vivo model with patient tissue validation, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"30030593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The Salmonella effector SseK1 binds TBCB (identified by yeast two-hybrid) and catalyzes N-acetylglucosamine addition to arginine residues on TBCB; this modification stabilizes the host microtubule cytoskeleton. The SseK1 DxD motif is required for both TBCB binding/modification and the cytoskeletal effect.\",\n      \"method\": \"Yeast two-hybrid screen, glycosyltransferase activity assay (in cellulo), DxD active-site mutagenesis, microtubule stability assay in HEK293T cells\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus active-site mutagenesis and functional cytoskeletal assay, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"32366039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TBCE/TBCB together dissociate tubulin heterodimers, and colchicine inhibits this dissociation, likely by interfering with TBCE–tubulin dimer interactions, leading to accumulation of free TBCA. The TBCE/TBCB + TBCA system recycles pre-existing tubulin heterodimers (rather than newly synthesized tubulins) to control the pool of free tubulin heterodimers and microtubule dynamics. Manipulation of TBCA levels by RNAi or overexpression decreased tubulin heterodimer levels, confirming functional coupling.\",\n      \"method\": \"In vitro tubulin dissociation assays with colchicine, RNAi knockdown and overexpression of TBCA, western blot of TBCA/β-tubulin complexes in colchicine-treated human cells, comparison with nocodazole/cold shock/cycloheximide controls\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro assays combined with RNAi and OE experiments and cell-based validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"33968934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TBCB (CKAP1) encodes a protein containing a CAP-Gly domain conserved among cytoskeleton-associated proteins; the CAP-Gly domain is thought to be essential for microtubule association. The gene maps to chromosome 19q13.11→q13.12.\",\n      \"method\": \"cDNA cloning from human fetal-brain library, Northern blot, FISH chromosomal mapping\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3–4 / Weak — initial cloning and mapping; CAP-Gly function in microtubule association is inferred from domain conservation, not directly demonstrated for this protein\",\n      \"pmids\": [\"8978778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A homozygous loss-of-function variant in TBCB (p.Tyr197Asn) reduces TBCB protein levels in patient fibroblasts and causes a neurodevelopmental disorder with spastic paraparesis. The yeast ortholog ALF1 carrying the equivalent mutation shows increased benomyl sensitivity (a microtubule-destabilizing agent), consistent with impaired tubulin-folding function. A CRISPR-Cas9 homologous mutant in Drosophila displays reduced survival and impaired climbing, confirming an essential role of TBCB in neuronal/axonal function.\",\n      \"method\": \"Exome sequencing, western blot and immunofluorescence in patient fibroblasts, yeast ALF1 mutant benomyl sensitivity assay, CRISPR-Cas9 Drosophila model with climbing/survival phenotype\",\n      \"journal\": \"Genetics in medicine : official journal of the American College of Medical Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function established via patient fibroblasts, yeast ortholog functional assay, and Drosophila CRISPR model with defined phenotypic readouts; single study but multiple orthogonal model systems\",\n      \"pmids\": [\"40856104\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TBCB is a tubulin-folding chaperone that binds α-tubulin intermediates emerging from CCT and acts together with TBCE to dissociate αβ-tubulin heterodimers in an energy-independent, steric mechanism (structurally defined by cryo-EM/X-ray); the resulting TBCE–TBCB–α-tubulin ternary complex can direct α-tubulin toward proteasomal degradation, while free β-tubulin is captured by TBCA for recycling. TBCB protein stability is regulated by Gigaxonin-mediated ubiquitination, PAK1-mediated phosphorylation, and HSP90 interaction (modulated by HILI/PIWIL2), and its abundance is post-transcriptionally controlled by miR-1825; excess TBCB destabilizes microtubules and degrades specific α-tubulin isoforms (e.g., TUBA4A), while loss-of-function variants in TBCB cause neurodevelopmental disease with spastic paraparesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TBCB is a tubulin-folding cofactor that controls the cellular pool of αβ-tubulin heterodimers and thereby microtubule dynamics [#0, #6]. It stably engages α-tubulin folding intermediates emerging from the CCT chaperonin as an obligate step in de novo heterodimer formation; a pachygyria-causing TUBA1A R264C mutation disrupts this interaction and reduces assembly efficiency [#1]. Acting together with TBCE, TBCB forms a binary complex that greatly enhances dissociation of αβ-tubulin heterodimers, after which TBCE, TBCB, and α-tubulin form a ternary complex while free β-tubulin is recovered by TBCA [#0]. Structural work on the human TBCE–TBCB–α-tubulin complex established that dissociation is energy-independent, driven by steric interaction between β-tubulin and the TBCE CAP-Gly and LRR domains, with protruding UBL domains positioned to direct α-tubulin to the proteasome [#2]; this TBCE/TBCB–TBCA system recycles pre-existing rather than newly synthesized heterodimers and is inhibited by colchicine [#6]. TBCB abundance is tightly regulated: HILI (PIWIL2) promotes HSP90 binding and suppresses Gigaxonin-mediated ubiquitination and PAK1-mediated phosphorylation to stabilize TBCB and destabilize microtubules [#3], while miR-1825 controls TBCB translation, and excess TBCB depolymerizes and degrades the α-tubulin isoform TUBA4A, causing motor axon defects [#4]. The Salmonella effector SseK1 binds and Arg-GlcNAcylates TBCB to stabilize the host microtubule cytoskeleton [#5]. A homozygous loss-of-function TBCB variant (p.Tyr197Asn) reduces TBCB protein levels and causes a neurodevelopmental disorder with spastic paraparesis, with corroborating microtubule-destabilization and neuronal phenotypes in yeast and Drosophila models [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Established that TBCB does not act alone but partners with TBCE to actively dissociate tubulin heterodimers, defining its place in the tubulin-cofactor cycle.\",\n      \"evidence\": \"Overexpression, in vitro tubulin dissociation assays, and complex characterization showing TBCB enhances TBCE dissociation activity and forms a TBCE–TBCB–α-tubulin ternary complex with β-tubulin recovered by TBCA\",\n      \"pmids\": [\"17184771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the atomic mechanism of dissociation\", \"Fate of the ternary complex (e.g., degradation routing) not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showed TBCB acts upstream in biogenesis by capturing CCT-generated α-tubulin intermediates, making it an obligate step in de novo heterodimer formation rather than only a recycling factor.\",\n      \"evidence\": \"In vitro folding/assembly reconstitution, co-IP of TBCB with CCT intermediates, and functional comparison of wild-type vs. R264C TUBA1A\",\n      \"pmids\": [\"18199681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define how TBCB hands off intermediates downstream\", \"Generalizability across α-tubulin isoforms not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the structural and energetic basis of heterodimer dissociation, revealing it is steric/energy-independent and positions α-tubulin for proteasomal degradation.\",\n      \"evidence\": \"Cryo-EM 3D reconstruction of the TBCE–TBCB–α-tubulin complex, X-ray crystallography of the TBCE UBL domain, and biochemical dissociation assays with domain docking\",\n      \"pmids\": [\"25908846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct proteasome engagement via UBL domains inferred from geometry, not demonstrated\", \"TBCB-specific contributions versus TBCE within the complex not fully separated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified post-translational control of TBCB stability, linking HILI/HSP90, Gigaxonin ubiquitination, and PAK1 phosphorylation to microtubule destabilization.\",\n      \"evidence\": \"Reciprocal co-IP of HILI–TBCB, HILI–HSP90–TBCB, and Gigaxonin–TBCB, plus ubiquitination, phosphorylation, and microtubule polymerization assays in a single lab\",\n      \"pmids\": [\"28393858\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No independent replication\", \"Phosphorylation sites and ubiquitination acceptor residues on TBCB not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Connected TBCB dosage to isoform-specific tubulin degradation and an in vivo neuronal phenotype, showing miR-1825 sets TBCB levels that govern TUBA4A stability.\",\n      \"evidence\": \"Transcriptomic/proteomic analysis, miRNA manipulation, in vivo motor axon phenotype assay, and western blot validation in patient tissue\",\n      \"pmids\": [\"30030593\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of TUBA4A selectivity over other α-tubulins unresolved\", \"Single lab, no independent replication\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed TBCB as a target of bacterial subversion, with the Salmonella effector SseK1 modifying TBCB to stabilize host microtubules.\",\n      \"evidence\": \"Yeast two-hybrid screen, in cellulo glycosyltransferase assay, DxD active-site mutagenesis, and microtubule stability assay in HEK293T cells\",\n      \"pmids\": [\"32366039\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Arg-GlcNAcylated residues on TBCB not mapped\", \"How modification mechanistically alters TBCB function in the cofactor cycle unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Clarified that the TBCE/TBCB + TBCA system recycles pre-existing heterodimers to control free tubulin pools, and that colchicine blocks this dissociation step.\",\n      \"evidence\": \"In vitro dissociation assays with colchicine, TBCA RNAi and overexpression, and western blot of TBCA/β-tubulin complexes in human cells with control comparisons\",\n      \"pmids\": [\"33968934\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct colchicine binding site within the dissociation machinery not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established TBCB loss-of-function as a cause of human neurodevelopmental disease, tying its tubulin-folding role to axonal/neuronal function across species.\",\n      \"evidence\": \"Exome sequencing, patient fibroblast western blot/immunofluorescence, yeast ALF1 mutant benomyl-sensitivity assay, and CRISPR-Cas9 Drosophila climbing/survival phenotype\",\n      \"pmids\": [\"40856104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single index variant/family; allelic spectrum unknown\", \"Cellular mechanism linking reduced TBCB to spastic paraparesis not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TBCB dosage, post-translational regulation, and isoform-selective α-tubulin handling integrate to produce tissue-specific neuronal vulnerability remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural account of how TBCB discriminates α-tubulin isoforms such as TUBA4A\", \"Regulatory inputs (Gigaxonin, PAK1, HILI, miR-1825) not integrated into a quantitative model of TBCB abundance in neurons\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 1, 2, 6]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [\"TBCE–TBCB–α-tubulin ternary complex\"],\n    \"partners\": [\"TBCE\", \"TBCA\", \"CCT\", \"PIWIL2\", \"HSP90\", \"GAN\", \"PAK1\", \"SseK1\"],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":7,"faith_pct":85.71428571428571}}